Rifaximin potentiates clarithromycin against Mycobacterium abscessus in vitro and in zebrafish.
Goh BC, Larsson S, Dam LC, Ling YHS, Chua WLP, Abirami R, Singh S, Ong JLE, Teo JWP, Ho P, Ingham PW, Pethe K, Dedon PC.
Goh BC, et al. Among authors: singh s.
JAC Antimicrob Resist. 2023 May 8;5(3):dlad052. doi: 10.1093/jacamr/dlad052. eCollection 2023 Jun.
JAC Antimicrob Resist. 2023.
PMID: 37168836
Free PMC article.